Medical Program: NCCN Guidelines on mCRC in an Era of Tumor Sidedness

NCCN Guidelines on mCRC in an Era of Tumor Sidedness

NCCN Guidelines on mCRC in an Era of Tumor Sidedness
RestartResume
Recently incorporating tumor sidedness in its guidelines, the NCCN differentiates between right-sided and left-sided treatment options.
  • Overview

    Keeping up with rapid advancements in mCRC, the NCCN updated their guidelines to encompass the perplexity of tumor sidedness. Dr. Benjamin Weinberg, Assistant Professor at Georgetown University, interprets the distinctions between right versus left-sided tumor sites and how these developments could impact your treatment selection for patients.

    Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facebook Comments

Sign up for the Global Oncology Academy newsletters.
Comprehensive Oncology Education.

Better education for a better you.

* Required
Optional

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free